Investigational Site

Brussels, Brussels Capital 1200

0 studies enrolling now · 1 studies all time

What they study most

Anemia, Primary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts)

Studies at this site

• Efficacy and Safety of Roxadustat for Treatment of Anemia in Participants With Lower Risk Myelodysplastic Syndrome With Low Red Blood Cell Transfusion Burden — Stopped early